Moderna’s coronavirus vaccine is expected to be effective against new variants of the virus, according to the company.

In a Monday statement, the company said the two-dose vaccine “is expected to be protective against emerging strains detected to date” but added that out of “an abundance of caution,” they have decided to implement a “clinical strategy to proactively address the pandemic as the virus continues to evolve.”